SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-99-001478
Filing Date
1999-03-24
Accepted
1999-03-24 00:00:00
Documents
10
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 BIOGEN, INC. 10-K 90112
2 LETTER AGREEMENT EX-10.2 2841
3 LETTER AGREEMENT EX-10.5 2878
4 LETTER AGREEMENT EX-10.9 2733
5 AMENDMENT #2 TO SAVINGS PLAN EX-10.31 1258
6 AMENDMENT TO DIRECTORS SAVINGS PLAN EX-10.35 1134
7 INCORPORATED PORTION OF A/R TO SHAREHOLDERS EX-13 126160
8 SUBSIDIARIES OF THE REGISTRANT EX-21 1293
9 CONSENT OF PRICEWATERHOUSECOOPERS EX-24.1 953
10 FINANCIAL DATA SCHEDULE EX-27 2469
  Complete submission text file 0000950135-99-001478.txt   234255
Mailing Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 6176792000
BIOGEN INC (Filer) CIK: 0000714655 (see all company filings)

IRS No.: 043002117 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12042 | Film No.: 99571842
SIC: 2836 Biological Products, (No Diagnostic Substances)